Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Core Laboratories (CLB) Revenue (2022 - 2026)

Core Laboratories filings provide 5 years of Revenue readings, the most recent being $121.8 million for Q1 2026.

  • On a quarterly basis, Revenue fell 1.45% to $121.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was $524.7 million, a 1.34% increase, with the full-year FY2025 number at $526.5 million, up 0.51% from a year prior.
  • Revenue hit $121.8 million in Q1 2026 for Core Laboratories, down from $138.3 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $138.3 million in Q4 2025 to a low of $120.9 million in Q2 2022.
  • Median Revenue over the past 5 years was $128.3 million (2023), compared with a mean of $128.5 million.
  • Biggest five-year swings in Revenue: rose 7.22% in 2024 and later decreased 4.67% in 2025.
  • Core Laboratories' Revenue stood at $127.6 million in 2022, then increased by 0.5% to $128.2 million in 2023, then grew by 0.8% to $129.2 million in 2024, then grew by 6.98% to $138.3 million in 2025, then decreased by 11.9% to $121.8 million in 2026.
  • The last three reported values for Revenue were $121.8 million (Q1 2026), $138.3 million (Q4 2025), and $134.5 million (Q3 2025) per Business Quant data.